학술논문

Integrated Molecular Characterization of Testicular Germ Cell Tumors
Document Type
article
Author
Shen, HuiShih, JuliannHollern, Daniel PWang, LinghuaBowlby, ReanneTickoo, Satish KThorsson, VésteinnMungall, Andrew JNewton, YuliaHegde, Apurva MArmenia, JoshuaSánchez-Vega, FranciscoPluta, JohnPyle, Louise CMehra, RohitReuter, Victor EGodoy, GuilhermeJones, JeffreyShelley, Carl SFeldman, Darren RVidal, Daniel OLessel, DavorKulis, TomislavCárcano, Flavio MLeraas, Kristen MLichtenberg, Tara MBrooks, DeniseCherniack, Andrew DCho, JuokHeiman, David IKasaian, KatayoonLiu, MinweiNoble, Michael SXi, LiuZhang, HaileiZhou, WandingZenKlusen, Jean CHutter, Carolyn MFelau, InaZhang, JiashanSchultz, NikolausGetz, GadMeyerson, MatthewStuart, Joshua MAkbani, RehanWheeler, DavidLaird, Peter WNathanson, Katherine LCortessis, Victoria KHoadley, Katherine AWheeler, David AHughes, DanielCovington, KyleJayaseelan, Joy CKorchina, ViktoriyaLewis, LoraHu, JianhongDoddapaneni, HarshaVardhanMuzny, DonnaGibbs, RichardHollern, DanielVincent, Benjamin GChai, ShengjieSmith, Christof CAuman, J ToddShi, YanMeng, ShaowuSkelly, TaraTan, DonghuiVeluvolu, UmadeviMieczkowski, Piotr AJones, Corbin DWilkerson, Matthew DBalu, SaianandBodenheimer, TomHoyle, Alan PJefferys, Stuart RMose, Lisle ESimons, Janae VSoloway, Matthew GRoach, JeffreyParker, Joel SHayes, D NeilPerou, Charles MSaksena, GordonCibulskis, CarrieSchumacher, Steven EBeroukhim, RameenGabriel, Stacey BAlly, Adrian
Source
Cell Reports. 23(11)
Subject
Urologic Diseases
Rare Diseases
Human Genome
Cancer
Biotechnology
Genetics
DNA Copy Number Variations
DNA Methylation
Gene Expression Regulation
Neoplastic
Humans
Male
MicroRNAs
Neoplasms
Germ Cell and Embryonal
Proto-Oncogene Proteins c-kit
Seminoma
Testicular Neoplasms
ras Proteins
Cancer Genome Atlas Research Network
DNA methylation
KIT
The Cancer Genome Atlas
copy number
exome sequencing
miR-375
nonseminoma
seminoma
testicular germ cell tumors
Biochemistry and Cell Biology
Medical Physiology
Language
Abstract
We studied 137 primary testicular germ cell tumors (TGCTs) using high-dimensional assays of genomic, epigenomic, transcriptomic, and proteomic features. These tumors exhibited high aneuploidy and a paucity of somatic mutations. Somatic mutation of only three genes achieved significance-KIT, KRAS, and NRAS-exclusively in samples with seminoma components. Integrated analyses identified distinct molecular patterns that characterized the major recognized histologic subtypes of TGCT: seminoma, embryonal carcinoma, yolk sac tumor, and teratoma. Striking differences in global DNA methylation and microRNA expression between histology subtypes highlight a likely role of epigenomic processes in determining histologic fates in TGCTs. We also identified a subset of pure seminomas defined by KIT mutations, increased immune infiltration, globally demethylated DNA, and decreased KRAS copy number. We report potential biomarkers for risk stratification, such as miRNA specifically expressed in teratoma, and others with molecular diagnostic potential, such as CpH (CpA/CpC/CpT) methylation identifying embryonal carcinomas.